MedTech Summit is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Peter Schroeer
EMEA Vice President Medical, Clinical, Regulatory Affairs Medical Devices at Johnson & Johnson, Belgium

Profile

Peter has a background in chemical engineering and started his career in the chemical industry, where he served as a production manager. In the medical devices industry, he set up manufacturing and servicing structures for active and passive medical devices, and led Quality System as well as product certification programs according to international standards, national and EU medical device regulations. He is a certified EOQ (European Organization for Quality) Quality Manager and auditor. Since joining Johnson & Johnson in 1996, Peter served as the authorized representative for various Business Units, led the Ethicon EMEA Quality and Regulatory group and established the MD&D regional regulatory affairs council. He established and led the EMEA ONE Ethicon and Global Surgery RA Teams and more recently led the global regulatory policy and innovation team for the medical devices sector. As the Senior Director Policy Innovation, he was responsible for ensuring global regulatory policies are appropriately interpreted, effectively communicated and efficiently implemented in the Johnson & Johnson Medical Devices companies. He is an active member of MedTech Europe where he is the Vice Chair of the Regulatory Affairs Council, Chair of the Reuse Task Force and an active member of a number of working groups.  Peter is a published author for regulatory affairs topics and as such is often requested to speak as an expert around the world, including presentations in the European Union’s Parliament.

In his current role as Medical Clinical Regulatory EMEAC Vice President, Johnson & Johnson Medical Devices Companies, he is building an integrated team to ensure medical, clinical and regulatory affairs needs of the EMEAC region are meet.

Peter Schroeer's Network

Agenda Sessions

  • Class 3 implantables: Understanding the new process for class 3 implantables

    ,